Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Regeneron Pharmaceuticals Inc](/topic/regeneron-pharmaceuticals-inc)

### Price: $XXXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:regeneron-pharmaceuticals-inc/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/regeneron-pharmaceuticals-inc/time-series/close.tsv)  
The stock price is currently at $567.70, down XX% due to a failed COPD trial, but the positive social sentiment and strong discussion around Dupixent's growth suggest a potential rebound.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| XXXX%   | -XXXX% | XXX%   |

**1-Year High**: $XXXXXXXX on 2024-08-27  
**1-Year Low**: $XXXXXX on 2025-06-05

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Regeneron Pharmaceuticals Inc

Price: $XXXXXX

Price Line Chart
Price 24-Hour Chart Data
The stock price is currently at $567.70, down XX% due to a failed COPD trial, but the positive social sentiment and strong discussion around Dupixent's growth suggest a potential rebound.

24-Hour 7-Day 30-Day
XXXX% -XXXX% XXX%

1-Year High: $XXXXXXXX on 2024-08-27
1-Year Low: $XXXXXX on 2025-06-05

Regeneron Pharmaceuticals Inc (REGN) Price
/topic/regeneron-pharmaceuticals-inc/close